Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

BACKGROUND: VIRTUE was a prospective, observational study assessing the effectiveness and safety of vildagliptin vs sulfonylureas (SUs) (both as monotherapy and in combination with metformin) in patients with type 2 diabetes mellitus who fasted during Ramadan. A post hoc analysis was carried out to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Metab Syndr Obes
Autors principals: Hassoun, Ahmed AK, Pathan, Md Faruque, Medlej, Rita C, Alarouj, Monira, Shaltout, Inass, Chawla, Manoj S, Knap, Ditte, Vaz, Julius A
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968856/
https://ncbi.nlm.nih.gov/pubmed/27555791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S103692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars